AN2 Therapeutics, Inc. (ANTX) ROA
- 2026-06-30: ROA -44.37%.
- 2026-03-31: ROA -39.45%.
- 2025-12-31: ROA -56.72%.
- 2025-09-30: ROA -50.55%.
Complete source-backed roa history.
- Available history
- 2021-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|
| 2026-06-30 | -44.37% |
|---|
| 2026-03-31 | -39.45% |
|---|
| 2025-12-31 | -56.72% |
|---|
| 2025-09-30 | -50.55% |
|---|
| 2025-06-30 | -49.30% |
|---|
| 2025-03-31 | -55.75% |
|---|
| 2024-12-31 | -55.73% |
|---|
| 2024-09-30 | -62.17% |
|---|
| 2024-06-30 | -59.63% |
|---|
| 2024-03-31 | -54.48% |
|---|
| 2023-12-31 | -46.68% |
|---|
| 2023-09-30 | -38.80% |
|---|
| 2023-06-30 | -54.90% |
|---|
| 2023-03-31 | -53.38% |
|---|
| 2022-12-31 | -39.93% |
|---|
| 2022-09-30 | -33.32% |
|---|
| 2022-06-30 | -26.88% |
|---|
| 2022-03-31 | -22.53% |
|---|
| 2021-12-31 | -32.98% |
|---|
Annual ROA
| Date | ROA |
|---|
| 2025-12-31 | -56.78% |
|---|
| 2024-12-31 | -55.73% |
|---|
| 2023-12-31 | -46.66% |
|---|
| 2022-12-31 | -39.93% |
|---|
| 2021-12-31 | -32.98% |
|---|